Papers: 10.1371/journal.pone.0240489

https://doi.org/10.1371/journal.pone.0240489

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

Cited by: 3
Author(s): Alison Evans, Miranda Davies, Vicki Osborne, Debabrata Roy, Saad Shakir
Published: almost 6 years ago

Software Mentions 1